Rating History for SAB Biotherapeutics (SABS) by Citi
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/22/2026 | Samantha Semenkow | New Coverage | Buy (N/A) |
11.00 (N/A) |
3.81 (4.00) |
4.99% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/22/2026 | Samantha Semenkow | New Coverage | Buy (N/A) |
11.00 (N/A) |
3.81 (4.00) |
4.99% | Details |